Business Expansion Ascentium acquisitions India: Smart Growth Strategy Ahead November 2, 2026 Vincent Hughes
Pharmaceuticals Valganciclovir oral solution: Proven Safe Treatment for Patients October 27, 2026 Vincent Hughes
healthcare Cancer Treatment Costs India: What Are the Real Solutions? October 19, 2026 Vincent Hughes
Business Expansion Ascentium acquisitions India: Smart Growth Strategy Ahead November 2, 2026 Vincent Hughes Ascentium acquisitions India are set to drive growth in the market, expanding their influence and capabilities in the region.
pharma Are Cancer Drug Price Cuts the Worst for Patients? October 30, 2026 Vincent Hughes Cancer drug price cuts fail to deliver real benefits to patients using expensive brands.
Pharmaceuticals Valganciclovir oral solution: Proven Safe Treatment for Patients October 27, 2026 Vincent Hughes Valganciclovir oral solution offers a proven safe treatment option for patients needing antiviral therapy.
pharma FDA Accelerated Approval: Is Ultomiris the Best Option? October 22, 2026 Vincent Hughes FDA accelerated approval has been granted to Ultomiris for IgAN treatment, offering new hope for patients.
healthcare Cancer Treatment Costs India: What Are the Real Solutions? October 19, 2026 Vincent Hughes Cancer treatment costs India are rising. Can Article 21 provide effective price regulation?
pharma FDA Approval for Liver Cancer Drug: Clear Path Ahead October 15, 2026 Vincent Hughes FDA approval liver cancer drug is anticipated this year as HLB resolves manufacturing issues.
Pharmaceuticals Price Caps on Life-Saving Drugs: A Smart Step Forward October 10, 2026 Vincent Hughes Price caps on life-saving drugs are crucial for patient access and affordability.
Pharmaceuticals Keytruda patent claims face tough fight with proven strategies October 7, 2026 Vincent Hughes Keytruda patent claims are creating challenges for Halozyme and Merck in Europe.
Pharma News SpyGlass Pharma stock: Best Buy Rating from Stifel October 2, 2026 Vincent Hughes SpyGlass Pharma stock receives a proven Buy rating from Stifel amid acquisition news.
Pharma News Sun Pharma Debt Sale: Smart Move for Refinancing September 29, 2026 Vincent Hughes Sun Pharma debt sale plans aim to refinance the Organon acquisition bridge loan for better financial stability.